Molecular profiling analysis for colorectal cancer patients with Pi-Xu or Shi-Re syndrome

[1]  J. Eberwine,et al.  Analysis of gene expression in single live neurons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Ji,et al.  [General methods for clinical effect assessment of traditional Chinese medicine]. , 2005, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[3]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[4]  Pan Du,et al.  lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..

[5]  Z. Bian,et al.  The Quintessence of Traditional Chinese Medicine: Syndrome and Its Distribution among Advanced Cancer Patients with Constipation , 2012, Evidence-based complementary and alternative medicine : eCAM.

[6]  Zhizhen Liu,et al.  Traditional Chinese medicine syndrome-related herbal prescriptions in treatment of malignant tumors. , 2013, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[7]  Jeffrey T. Leek,et al.  Preserving biological heterogeneity with a permuted surrogate variable analysis for genomics batch correction , 2014, Bioinform..

[8]  Min Gyu Lee,et al.  UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells. , 2014, Cancer research.

[9]  C. Ling,et al.  Three advantages of using traditional Chinese medicine to prevent and treat tumor. , 2014, Journal of integrative medicine.

[10]  Ai-ping Lv.  [Zheng Classification in Chinese Medicine: from Its Integration with Disease Diagnosis to Clinical Effectiveness Assessment and Combinational New Drug Discovery]. , 2015, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[11]  Xinbing Sui,et al.  The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients , 2015, Oncotarget.

[12]  S. Su,et al.  Research advances in traditional Chinese medicine syndromes in cancer patients. , 2016, Journal of integrative medicine.

[13]  S. Dieguez.  Ça , 2016, Cerveau & Psycho.

[14]  H. Hermeking,et al.  Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells. , 2017, Gastroenterology.

[15]  E. Kuipers,et al.  Surveillance after curative treatment for colorectal cancer , 2017, Nature Reviews Clinical Oncology.

[16]  J. Guinney,et al.  Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer , 2017, Nature Reviews Cancer.

[17]  Tian Xie,et al.  Inflammatory microenvironment in the initiation and progression of bladder cancer , 2017, Oncotarget.

[18]  Hua Wang,et al.  PSMB4 overexpression enhances the cell growth and viability of breast cancer cells leading to a poor prognosis. , 2018, Oncology reports.

[19]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.